Hikal Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
277
137
192
165
272
Total Accounts Receivable
1,320
1,507
1,280
2,641
2,984
Inventories
3,113
3,200
2,984
2,681
3,156
Other Current Assets
236
287
216
279
488
Total Current Assets
4,946
5,131
4,672
5,765
6,900
Net Property, Plant & Equipment
7,050
7,010
6,994
7,365
7,561
Total Investments and Advances
134
139
101
144
98
Long-Term Note Receivable
439
559
2
2
3
Intangible Assets
-
-
6
15
58
Other Assets
127
203
975
399
793
Total Assets
12,769
13,128
12,835
13,795
15,417
ST Debt & Current Portion LT Debt
2,910
3,457
2,124
2,777
3,385
Accounts Payable
1,312
1,372
1,238
1,304
1,645
Income Tax Payable
15
144
23
22
9
Other Current Liabilities
430
328
359
297
562
Total Current Liabilities
4,667
5,301
3,744
4,400
5,600
Long-Term Debt
2,548
2,014
2,966
3,202
2,966
Provision for Risks & Charges
109
117
102
143
156
Deferred Taxes
325
285
300
102
5
Total Liabilities
7,722
7,803
7,197
7,745
8,723
Common Equity (Total)
5,042
5,319
5,632
6,044
6,688
Total Shareholders' Equity
5,042
5,319
5,632
6,044
6,688
Total Equity
5,042
5,319
5,632
6,044
6,688
Liabilities & Shareholders' Equity
12,769
13,128
12,835
13,795
15,417
Non-Equity Reserves
6
6
6
6
6

About Hikal

View Profile
Address
Great Eastern Chambers, 6 Floor
Mumbai Maharashtra 400614
India
Employees -
Website http://www.hikal.com
Updated 09/14/2018
Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. It operates through the Crop Protection and Pharmaceuticals segments. The Crop Protection segment involves in manufacturing of intermediates and active ingredients.